Meg Wood MPH

Meg Wood joined the CureDuchenne team in 2016 as the Eastern Director of Development. She is a ten year veteran of Boston’s healthcare & biotechnology industry, most recently coming from MPM Capital – an early stage venture group. At MPM Capital, Meghan was marketing lead for several investment funds including the Oncology Impact Fund ($450M) for early stage oncology science.
Before MPM Capital, Meg was a public health manager at Tufts Medical Center and Boston Medical Center. She was responsible for hospital population management, ambulatory patient experience, and patient cost saving initiatives. Meg has both a Master of Public Health and Master of Social Work degree from Boston University.